A prospective study of infliximab withdrawal after 12 months of treatment in patients with Crohn's disease: how will NICE guidance affect patient care? [electronic resource]
Producer: 20120820Description: 235-8 p. digitalISSN:- 1470-2118
- Adult
- Antibodies, Monoclonal -- economics
- Crohn Disease -- drug therapy
- Female
- Gastrointestinal Agents -- economics
- Humans
- Immunologic Factors -- economics
- Infliximab
- Male
- Medication Therapy Management -- standards
- Practice Guidelines as Topic -- standards
- Product Recalls and Withdrawals -- standards
- Prospective Studies
- Remission Induction -- methods
- Secondary Prevention
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.